Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
601A anti-VEGF Ab by Sunshine Guojian Pharmaceutical Shanghai for Branch Retinal Vein Occlusion: Likelihood of Approval
601A anti-VEGF Ab is under clinical development by Sunshine Guojian Pharmaceutical Shanghai and currently in Phase III for Branch Retinal...
601A anti-VEGF Ab by Sunshine Guojian Pharmaceutical Shanghai for Age Related Macular Degeneration: Likelihood of Approval
601A anti-VEGF Ab is under clinical development by Sunshine Guojian Pharmaceutical Shanghai and currently in Phase II for Age Related...
601A anti-VEGF Ab by Sunshine Guojian Pharmaceutical Shanghai for Diabetic Macular Edema: Likelihood of Approval
601A anti-VEGF Ab is under clinical development by Sunshine Guojian Pharmaceutical Shanghai and currently in Phase II for Diabetic Macular...